John A. Corbett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John A. Corbett has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Aaron Naatz
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
15 shared publicationsBryndon J. Oleson
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
14 shared publications- Katarzyna A. Broniowska
From the Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 and
10 shared publications Jennifer S. Stancill
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
7 shared publicationsPolly A. Hansen
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
7 shared publicationsJoshua D. Stafford
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
6 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (11) , e202603795
Interleukin-1 mediates innate immune signaling and antiviral defense in islets
Based on in vitro studies, cytokines are believed to contribute to the pathogenesis of type 1 diabetes by directly causing β-cell damage. In this study, the effects of endogenously produced cytokines, following lipopolysaccharide (LPS) administration to mice, on gene expression in islet cells were evaluated by single-cell RNA sequencing (scRNA-seq). In response to LPS, there is an increase in antiviral and antibacterial genes and repression of genes associated with identity in all endocrine cell populations. While islet-resident non-lymphoid hematopoietic cells were not classically activated, antiviral and antibacterial gene expression was increased. Antipathogen gene expression was also increased in the islet endothelium, while genes associated with transcription, cell migration, and adhesion were decreased. IL-1 was identified as the primary mediator of changes in β-cell gene expression, and we show that IL-1 limits picornavirus replication in islets. Overall, these findings support a role for IL-1-stimulated antipathogen gene expression in β-cells as a physiologically relevant immune-endocrine signaling axis that functions to enhance fitness and reduce susceptibility of these essential cells to virus-mediated damage.
- 25 August 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (11) , e202603795
Open AccessInterleukin-1 mediates innate immune signaling and antiviral defense in islets
Based on in vitro studies, cytokines are believed to contribute to the pathogenesis of type 1 diabetes by directly causing β-cell damage. In this study, the effects of endogenously produced cytokines, following lipopolysaccharide (LPS) administration to mice, on gene expression in islet cells were evaluated by single-cell RNA sequencing (scRNA-seq). In response to LPS, there is an increase in antiviral and antibacterial genes and repression of genes associated with identity in all endocrine cell populations. While islet-resident non-lymphoid hematopoietic cells were not classically activated, antiviral and antibacterial gene expression was increased. Antipathogen gene expression was also increased in the islet endothelium, while genes associated with transcription, cell migration, and adhesion were decreased. IL-1 was identified as the primary mediator of changes in β-cell gene expression, and we show that IL-1 limits picornavirus replication in islets. Overall, these findings support a role for IL-1-stimulated antipathogen gene expression in β-cells as a physiologically relevant immune-endocrine signaling axis that functions to enhance fitness and reduce susceptibility of these essential cells to virus-mediated damage.
- Open Access
- 13 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110811
Lipopolysaccharide-induced cytokine signaling activates a temporal innate defense program and represses pancreatic β-cell identity
- 13 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110811
Open AccessLipopolysaccharide-induced cytokine signaling activates a temporal innate defense program and represses pancreatic β-cell identity
- Open Access
- 9 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110798
Nitric oxide attenuates PI4P accumulation at the ER membrane to inhibit encephalomyocarditis virus replication selectively in β-cells
- 9 October 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (12) , 110798
Open AccessNitric oxide attenuates PI4P accumulation at the ER membrane to inhibit encephalomyocarditis virus replication selectively in β-cells
- Open Access
- 26 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108451
Role of SIRT3 in the regulation of Gadd45α expression and DNA repair in β-cells
- 26 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108451
Open AccessRole of SIRT3 in the regulation of Gadd45α expression and DNA repair in β-cells
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (6) , R515-R527
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types
Inhibition of BET bromodomains is a novel potential strategy to prevent and treat diabetes mellitus. However, BET inhibitors have negative side effects. We synthesized a BET inhibitor expected to exploit the high zinc concentration in β cells to accumulate in β cells. We show our inhibitor targeted pancreatic endocrine cells; however, it was less effective in immune cells. A control inhibitor showed the opposite effect. These findings help us understand how to target specific cells in diabetes treatment.
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (6) , R515-R527
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types
Inhibition of BET bromodomains is a novel potential strategy to prevent and treat diabetes mellitus. However, BET inhibitors have negative side effects. We synthesized a BET inhibitor expected to exploit the high zinc concentration in β cells to accumulate in β cells. We show our inhibitor targeted pancreatic endocrine cells; however, it was less effective in immune cells. A control inhibitor showed the opposite effect. These findings help us understand how to target specific cells in diabetes treatment.
- Open Access
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (6) , R552-R566
β-Cell-selective regulation of gene expression by nitric oxide
Nitric oxide is produced at low micromolar levels following the induction of inducible nitric oxide synthase (iNOS) and is responsible for mediating the inhibitory actions of cytokines on glucose-stimulated insulin secretion by islets of Langerhans. It is through the inhibition of mitochondrial oxidative metabolism, specifically aconitase and complex 4 of the electron transport chain, that nitric oxide inhibits insulin secretion. Nitric oxide also attenuates protein synthesis, induces DNA damage, activates DNA repair pathways, and stimulates stress responses (unfolded protein and heat shock) in β-cells. In this report, the time- and concentration-dependent effects of nitric oxide on the expression of 6 genes known to participate in the response of β-cells to this free radical were examined. The genes included Gadd45α (DNA repair), Puma (apoptosis), Hmox1 (antioxidant defense), Hsp70 (heat shock), Chop (UPR), and ßPpargc1α (mitochondrial biogenesis). We show that nitric oxide stimulates β-cell gene expression in a narrow concentration range of ~0.5-1 µM, or levels corresponding to iNOS-derived nitric oxide. At concentrations greater than 1 µM, nitric oxide fails to stimulate gene expression in β-cells, and this is associated with the inhibition of mitochondrial oxidative metabolism. This narrow concentration range of responses is β-cell selective, as the actions of nitric oxide in non-β-cells (α-cells, mouse embryonic fibroblasts, and macrophages) are concentration-dependent. Our findings suggest that β-cells respond to a narrow concentration range of nitric oxide that is consistent with the levels produced following iNOS induction, and that these concentration-dependent actions are selective for insulin-containing cells.
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (6) , R552-R566
Open Accessβ-Cell-selective regulation of gene expression by nitric oxide
Nitric oxide is produced at low micromolar levels following the induction of inducible nitric oxide synthase (iNOS) and is responsible for mediating the inhibitory actions of cytokines on glucose-stimulated insulin secretion by islets of Langerhans. It is through the inhibition of mitochondrial oxidative metabolism, specifically aconitase and complex 4 of the electron transport chain, that nitric oxide inhibits insulin secretion. Nitric oxide also attenuates protein synthesis, induces DNA damage, activates DNA repair pathways, and stimulates stress responses (unfolded protein and heat shock) in β-cells. In this report, the time- and concentration-dependent effects of nitric oxide on the expression of 6 genes known to participate in the response of β-cells to this free radical were examined. The genes included Gadd45α (DNA repair), Puma (apoptosis), Hmox1 (antioxidant defense), Hsp70 (heat shock), Chop (UPR), and ßPpargc1α (mitochondrial biogenesis). We show that nitric oxide stimulates β-cell gene expression in a narrow concentration range of ~0.5-1 µM, or levels corresponding to iNOS-derived nitric oxide. At concentrations greater than 1 µM, nitric oxide fails to stimulate gene expression in β-cells, and this is associated with the inhibition of mitochondrial oxidative metabolism. This narrow concentration range of responses is β-cell selective, as the actions of nitric oxide in non-β-cells (α-cells, mouse embryonic fibroblasts, and macrophages) are concentration-dependent. Our findings suggest that β-cells respond to a narrow concentration range of nitric oxide that is consistent with the levels produced following iNOS induction, and that these concentration-dependent actions are selective for insulin-containing cells.
- Open Access
- 27 March 2024
- Published by American Physiological Society in Function
- Vol. 5 (4)
Single Cell RNAseq Analysis of Cytokine-Treated Human Islets: Association of Cellular Stress with Impaired Cytokine Responsiveness
Pancreatic β-cells are essential for survival, being the only cell type capable of insulin secretion. While they are believed to be vulnerable to damage by inflammatory cytokines such as interleukin-1 beta (IL-1β) and interferon-gamma, we have recently identified physiological roles for cytokine signaling in rodent β-cells that include the stimulation of antiviral and antimicrobial gene expression and the inhibition of viral replication. In this study, we examine cytokine-stimulated changes in gene expression in human islets using single-cell RNA sequencing. Surprisingly, the global responses of human islets to cytokine exposure were remarkably blunted compared to our previous observations in the mouse. The small population of human islet cells that were cytokine responsive exhibited increased expression of IL-1β-stimulated antiviral guanylate-binding proteins, just like in the mouse. Most human islet cells were not responsive to cytokines, and this lack of responsiveness was associated with high expression of genes encoding ribosomal proteins. We further correlated the expression levels of RPL5 with stress response genes, and when expressed at high levels, RPL5 is predictive of failure to respond to cytokines in all endocrine cells. We postulate that donor causes of death and isolation methodologies may contribute to stress of the islet preparation. Our findings indicate that activation of stress responses in human islets limits cytokine-stimulated gene expression, and we urge caution in the evaluation of studies that have examined cytokine-stimulated gene expression in human islets without evaluation of stress-related gene expression.
- 27 March 2024
- Published by American Physiological Society in Function
- Vol. 5 (4)
Open AccessSingle Cell RNAseq Analysis of Cytokine-Treated Human Islets: Association of Cellular Stress with Impaired Cytokine Responsiveness
Pancreatic β-cells are essential for survival, being the only cell type capable of insulin secretion. While they are believed to be vulnerable to damage by inflammatory cytokines such as interleukin-1 beta (IL-1β) and interferon-gamma, we have recently identified physiological roles for cytokine signaling in rodent β-cells that include the stimulation of antiviral and antimicrobial gene expression and the inhibition of viral replication. In this study, we examine cytokine-stimulated changes in gene expression in human islets using single-cell RNA sequencing. Surprisingly, the global responses of human islets to cytokine exposure were remarkably blunted compared to our previous observations in the mouse. The small population of human islet cells that were cytokine responsive exhibited increased expression of IL-1β-stimulated antiviral guanylate-binding proteins, just like in the mouse. Most human islet cells were not responsive to cytokines, and this lack of responsiveness was associated with high expression of genes encoding ribosomal proteins. We further correlated the expression levels of RPL5 with stress response genes, and when expressed at high levels, RPL5 is predictive of failure to respond to cytokines in all endocrine cells. We postulate that donor causes of death and isolation methodologies may contribute to stress of the islet preparation. Our findings indicate that activation of stress responses in human islets limits cytokine-stimulated gene expression, and we urge caution in the evaluation of studies that have examined cytokine-stimulated gene expression in human islets without evaluation of stress-related gene expression.
- Open Access
- 9 February 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , 102994
β-cell–selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptake
- 9 February 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , 102994
Open Accessβ-cell–selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptake
- 29 December 2022
- Published by Elsevier
- Vol. 121, 45-66
Hydrogen peroxide detoxification through the peroxiredoxin/thioredoxin antioxidant system: A look at the pancreatic β-cell oxidant defense
- 29 December 2022
- Published by Elsevier
- Vol. 121, 45-66
Hydrogen peroxide detoxification through the peroxiredoxin/thioredoxin antioxidant system: A look at the pancreatic β-cell oxidant defense
- Open Access
- 4 July 2022
- Published by American Physiological Society in Function
- Vol. 3 (4) , zqac034
Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function
Reactive oxygen species (ROS) have been implicated as mediators of pancreatic β-cell damage. While β-cells are thought to be vulnerable to oxidative damage, we have shown, using inhibitors and acute depletion, that thioredoxin reductase, thioredoxin, and peroxiredoxins are the primary mediators of antioxidant defense in β-cells. However, the role of this antioxidant cycle in maintaining redox homeostasis and β-cell survival in vivo remains unclear. Here, we generated mice with a β-cell specific knockout of thioredoxin reductase 1 (Txnrd1fl/fl; Ins1Cre/+, βKO). Despite blunted glucose-stimulated insulin secretion, knockout mice maintain normal whole-body glucose homeostasis. Unlike pancreatic islets with acute Txnrd1 inhibition, βKO islets do not demonstrate increased sensitivity to ROS. RNA-sequencing analysis revealed that Txnrd1-deficient β-cells have increased expression of nuclear factor erythroid 2-related factor 2 (Nrf2)-regulated genes, and altered expression of genes involved in heme and glutathione metabolism, suggesting an adaptive response. Txnrd1-deficient β-cells also have decreased expression of factors controlling β-cell function and identity which may explain the mild functional impairment. Together, these results suggest that Txnrd1-knockout β-cells compensate for loss of this essential antioxidant pathway by increasing expression of Nrf2-regulated antioxidant genes, allowing for protection from excess ROS at the expense of normal β-cell function and identity.
- 4 July 2022
- Published by American Physiological Society in Function
- Vol. 3 (4) , zqac034
Open AccessDeletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function
Reactive oxygen species (ROS) have been implicated as mediators of pancreatic β-cell damage. While β-cells are thought to be vulnerable to oxidative damage, we have shown, using inhibitors and acute depletion, that thioredoxin reductase, thioredoxin, and peroxiredoxins are the primary mediators of antioxidant defense in β-cells. However, the role of this antioxidant cycle in maintaining redox homeostasis and β-cell survival in vivo remains unclear. Here, we generated mice with a β-cell specific knockout of thioredoxin reductase 1 (Txnrd1fl/fl; Ins1Cre/+, βKO). Despite blunted glucose-stimulated insulin secretion, knockout mice maintain normal whole-body glucose homeostasis. Unlike pancreatic islets with acute Txnrd1 inhibition, βKO islets do not demonstrate increased sensitivity to ROS. RNA-sequencing analysis revealed that Txnrd1-deficient β-cells have increased expression of nuclear factor erythroid 2-related factor 2 (Nrf2)-regulated genes, and altered expression of genes involved in heme and glutathione metabolism, suggesting an adaptive response. Txnrd1-deficient β-cells also have decreased expression of factors controlling β-cell function and identity which may explain the mild functional impairment. Together, these results suggest that Txnrd1-knockout β-cells compensate for loss of this essential antioxidant pathway by increasing expression of Nrf2-regulated antioxidant genes, allowing for protection from excess ROS at the expense of normal β-cell function and identity.